BIOSPAIN 2026 concludes in Bilbao with focus on biotechnology

The BIOSPAIN 2026 conference concluded in Bilbao, bringing together over 1,900 delegates and approximately 900 entities from 32 countries. The event featured roughly 4,000 meetings involving researchers, investors, administrators, and students.

During the event, discussions focused on the potential of new technologies to advance personalized medicine. Key topics included smart biomaterials, advanced drug delivery systems, and advanced therapies designed to tailor treatments to individual patient needs. Experts emphasized that integrating controlled release technologies with advanced diagnostic tools is essential for improving treatment efficacy and reducing adverse effects.

Cristina Nadal, president of AseBio, noted the importance of the event for fostering investment and new initiatives, while highlighting the need for Europe to regain biotechnology competitiveness against China and the United States. The conference concluded with the announcement that Barcelona will host BIOSPAIN 2027, leveraging its extensive scientific and industrial infrastructure.